Monte Rosa Therapeutics Inc (GLUE)

Finanzdaten der Monte Rosa Therapeutics Inc-Aktie (GLUE)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	113.02%8.97	4.21	2.78	12.77	23.19
	7.10%58.10	54.24	52.50	45.74	38.75
Research and Development	8.84%47.96	44.07	41.98	36.68	30.65
Operating Income/Loss	1.81%-49.13	-50.03	-49.72	-32.98	-15.55
Nonoperating Income/Loss	6.41%5.94	5.58	3.64	2.72	4.46
Income/Loss From Continuing Operations Before Tax	2.84%-43.19	-44.45	-46.08	-30.26	-11.10
Income Tax Expense/Benefit	300.00%0.21	0.05	0.06	-3.18	1.20
	2.49%-43.40	-44.50	-46.14	-27.08	-12.30
Attributable To Parent	2.49%-43.40	-44.50	-46.14	-27.08	-12.30
Basic Average Shares	1.60%101.48	99.88	-	82.40	82.19
Diluted Average Shares	1.60%101.48	99.88	-	82.40	82.19